Introduction
Despite advances in dialysis treatment, such procedures do not guarantee the preservation of quality of life in patients with chronic renal disease. The attention to ensure quality of care for these patients can reduce the risk of hospitalization and death [1] . Several studies have demonstrated the importance and benefits of physical activity (PA) and exercise in patients who are on hemodialysis, such as increasing functional capacity, strength and quality of life [2] [3] [4] [5] . Monitoring and surveying habitual PA is of paramount importance in epidemiology studies among patients undergoing hemodialysis [6] . Consequently, there is a strong rationale for establishing the validity of methods to measure PA, which can be used in large cohort studies and enable comparisons across the globe.
As a field method, questionnaires are simple and cheap instruments to assess PA, and their validation is important among specific populations. Over the last decade, the International Physical Activity Questionnaire (IPAQ) has received special attention in the scientific literature. The IPAQ was created to fulfill the necessity to standardize the assessment of PA in different populations and cultures around the world, and its reliability and validity have been reported [7] . Therefore, the IPAQ has been considered as an acceptable tool that can be used not only in regional but also in national PA-monitoring studies across diverse populations.
In spite of the benefits that PA and exercise have in chronic renal disease patients who are undergoing hemodialysis, no study has examined the validity of the IPAQ in this population group. This is important, as questionnaires designed for the healthy population cannot be extrapolated onto disease populations, such as patients with chronic renal failure [8] .
The objective of this study, therefore, was to examine whether the IPAQ (short version) provides valid measures of PA in chronic kidney disease patients who are undergoing hemodialysis, when compared to objectively assessed PA using accelerometry.
Methodology

Participants and Study Design
Patients from 2 centers of hemodialysis in the countryside of São Paulo State (Brazil) were invited to participate in this cross-sectional study. These patients were randomly selected from standard patient treatment groups, which were classified according to the day of the week (Monday, Wednesday and Friday/Tuesday, Thursday and Saturday) and time of the day (morning, afternoon and night). Each of the 6 groups had ∼ 25 patients, and for the present study, 2 groups were randomly selected. The inclusion criteria to participate in this study were the following: (1) to be older than 18 years of age and (2) to have undertaken hemodialysis for more than 3 months. Patients in a wheelchair, those presenting disability or those who had had amputation and those with malformation of the lower limbs, causing impaired walking, were excluded from the study.
Fifty-one patients (54 ± 16 years) fulfilled the inclusion criteria. However, after data collection, 11 patients (6 men, 61 ± 9 years, and 5 women, 41 ± 9 years) were excluded from study, as they did not have valid PA data. Finally, 40 patients (19 men) with a mean age of 54 ± 16 years were included in this study. Clinical data of the patients, such as values of hemodialysis adequacy (Kt/V), creatinine and hemoglobin and body mass index (BMI) were collected from the hospital.
The procedures used in this study meet the criteria of the Ethics in Human Research according to resolution number 196/96 of the Brazilian Health Ministry, and the study was approved by the Ethical Research Committee of Universidade Estadual Paulista -UNESP (process number: 1048/46/01/10). All patients provided written consent to partake in the study.
Initially, all patients were given detailed instructions about wearing an accelerometer for a consecutive 8-day period; then, in a second meeting, the IPAQ (short version) questionnaire was applied through face-to-face interview by a trained researcher to assess the patients PA. All procedures were applied during a hemodialysis day.
IPAQ (Short Version)
The IPAQ was applied in its reduced version to assess a typical week of PA. The International Group proposed the IPAQ for Consensus on Measures of Physical Activity, under the seal of the World Health Organization, with representatives from 12 countries, including Brazil. It is an instrument developed to enable the estimation of the level of PA in populations across different countries and sociocultural contexts [7] .
The IPAQ is available in different languages, including Portuguese, meaning no translation was required for this study. The short version is composed of 8 questions that are used to estimate the time spent per week performing different PA intensities. The short form records the activity of 4 intensity levels: (1) vigorous-intensity activity such as aerobics, (2) moderate-intensity activity such as leisure cycling, (3) walking or light activity and (4) sitting. For all intensity levels, the patients were asked how many days per week and minutes per day they performed the activity for ≥ 10 min continually. To quantify the PA levels, the product of the duration (min/day) and frequency (days/week) were used to estimate light PA, moderate-to-vigorous PA (MVPA) and total PA. Sedentary time was not considered for the analysis.
Accelerometry
Actigraph GT3X (Actigraph LLC, Pensacola, FL) accelerometers were used to assess PA at different intensities. Accelerometers were placed on the patients' waist by using an elastic band. The patients wore the accelerometer for 8 days (7 were full days). The patients were instructed to wear the accelerometer during all their time awake and only to remove it for water-based activities, such as personal hygiene or swimming. The epoch (time sampling interval) was set at 60 s, as in this population, PA is typically of a low intensity and long duration [9] , which is standard for monitoring free-living adults [10] .
Data with periods of continuous zero values for more than 60 min were taken as the patient having removed the accelerometer. At least 5 days of recording with a minimum of ≥ 10 h of registration per day [7] were necessary for the patient to be included in the study. Commercially available software (ActiLife5 Data Analysis Software by Actigraph) was used for the data analysis.
The PA intensities were determined as follows: time spent in light intensity (100-1,951 counts/min) and time spent in moderate-to-vigorous intensity ( ≥ 1,952 counts/min) [11] . Time spent in sedentary behavior (<100 counts/min) was not computed in our analysis. In the present study, counts per minute in the vertical vector were used according to previous cut points available in the literature, since, nowadays, there are no 3-vector thresholds to distinguish sedentary time from light PA. Counts for vector magnitude per day (sum of the 3 axes) were calculated and compared with total time of questionnaire PA.
Statistical Analysis
Descriptive characteristics of the whole sample and by gender are provided. Continuous data are reported as means and SD for normally distributed variables or as median and interquartile intervals for non-normally distributed variables. Categorical data are reported as absolute values and percentages. Mean differences in descriptive characteristics were examined using the Mann-Whitney test (non-parametric data), the Student t test (parametric data) or the chi-square test (categorical data). The Wilcoxon test showed mean differences between the measurement tools and the Spearman's rank-order correlations were used to examine the strength of the relationship. All statistical analyses were performed using the Statistical Package for the Social Sciences statistical software (version 18.0, SPSS Inc., Chicago, Ill., USA), with the alpha level set at 0.05. 
Results
Descriptive Characteristics
The demographic and clinical statuses of the patients are reported in table 1 . Nineteen men and 21 women completed all data collection; the mean age of patients was 54 ± 16 years . Hypertension was the most prevalent primary disease (42.5%), followed by diabetes (17.5%) and interstitial nephrite (17.5%). Glomerular nephrite was the primary disease in 7.5% of the patients and 15% were indeterminate. Patient characteristics did not differ by gender, except with respect to creatinine and Kt/V.
Physical Activity
The total mean counts per day were 335,126 ± 170,441 (men 301,843 ± 153,979 and women 365,238 ± 182,496; p = 0.245). Table 2 lists the Spearman's rank-order correlations of the PA measures using accelerometer and IPAQ. There were modest, but significant, positive correlation for all intensities of PA, total PA and total counts/ min using accelerometry and IPAQ. When analyzed separately by gender, no relationships were found between the accelerometry-and IPAQ-measured PA among men, but positive relationships were found for women (r = 0.48-0.62). Table 3 presents descriptive data for PA measures using the accelerometer and IPAQ as a group and stratified by gender. For the overall group, patients reported that significantly lower time was spent performing light PA (p = 0.019) when measured using the IPAQ compared to the accelerometer. No other mean differences were observed in PA status between the assessment methods.
Discussion
To our knowledge, this is the first study to examine the validity of measuring the PA status of patients undergoing hemodialysis using both IPAQ (subjective) and accelerometry (objective) techniques. Our novel findings are the following: (1) for the whole group, modest positive correlations (r = 0.34-0.47) were found for measuring PA using the 2 methods, although when stratified by gender this positive relationship only remained for the female patients (r = 0.46-0.62) and (2) for the whole group, the IPAQ method significantly under-reported the time spent performing light PA when compared to the accelerometer method.
We are not aware of any other studies that have used the IPAQ to quantify the PA status of patients undergoing hemodialysis treatment. However, we can compare our data to studies conducted on other populations. Overall, correlations found in the present study are similar to those reported in the 12-Country Reliability and Validity Study of IPAQ, short version (r = 0.30) [7] , as well as to correlations reported in a recent systematic review (r = 0.39-0.90) [12] . An interesting finding in our study was that significant positive correlations between IPAQ-and accelerometermeasured PA were present only for the female patients. In general, the literature is inconsistent when examining gender differences between IPAQ-and accelerometerderived PA among the healthy population. In a recent study, researchers found significant correlation for total PA in men (r = 0.44) but not in women, while for moderate PA, a significant correlation was observed for women (r = 0.32) but not men [13] . However, others have reported no differences between men and women when comparing both instruments in a sample of Swedish adults [14] .
In the current study, the IPAQ was found to significantly underestimate light PA, and although data showed higher minutes per day of MVPA for the superior quartiles (75th; often by 270% the MVPA measured by accelerometer), this did not reach significance. In contrast, previous IPAQ studies have typically reported an overestimation of PA when compared to PA measured using an accelerometer [13] [14] [15] , mostly due to an overestimation for MVPA. For example, researchers have shown an overestimation in the MVPA time reported by the IPAQ short form in Swedish adults (aged 20-69 years; mean difference -25.9 min/day total PA; 95% limits of agreement -172 to 120 min/day) [14] . In a study with women diagnosed with breast cancer (average age 57 years), it has been reported that the IPAQ significantly overestimated moderate PA by 225 min/week (239%) and vigorous PA by 31 min/week (342%) [15] . In contrast to our data, the same study found that the total PA for the IPAQ was approximately 3-4 times greater than PA determined using accelerometers. Unfortunately, these studies did not present data for light PA separately.
Among the possibilities for differences between instruments in our sample include a lack of comprehension due to cognitive capacity and memory, as reported in previous studies [8] . It is possible that the under-reporting of time spent in light PA was related to a misreporting of activities in the home environment as our sample consisted of a large proportion (70%) of housewives and unemployed people. Unlike leisure-time PA, PA performed at work or in the domestic environment has considerable variation both within and between days with regard to the intensity, duration and rest periods associated with the PA. This may cause inconsistencies when self-reporting PA [8] . Yet, studies have shown that patients undergoing hemodialysis have low physical capacity compared to age-matched healthy counterparts [16, 17] . In addition to the time spent in hemodialysis (4-5 h of sedentary behavior), the time spent in travel to the dialysis unit (3 times per week) could have resulted in patients overestimating time spent sedentary. For this reason, it is possible that a self-report instrument that is modified for groups that undertake predominantly light intensity PA (i.e. is better able to capture light PA) would improve the reporting of PA among hemodialysis patients.
It should also be considered that the accelerometer 'cut points' used to assess PA in this study might not hold true for this population, and thus might have introduced error into the calculated levels of PA. Indeed, the cut points used in the current study were developed in a laboratory setting with younger adults during treadmill walking and running [11] , and it has been suggested that the method of accelerometer calibration can underestimate the time spent performing lifestyle activities such as housekeeping [18] . It could also be assumed that the impact of renal dis- ease on resting metabolic rate and the energy cost of exercise [19] would alter the relationship between metabolic rate and accelerometer counts in this patient group. Thus, patients in this population may be required to meet a lower 'cut point' to reach MVPA. Accelerometers also have a poor ability to assess movements such as cycling, walking uphill, upper body activities and carrying loads. In addition to these limitations, despite its homogeneity, our study included a small sample of patients. In the last 15 years, the number of studies aimed at investigating the relationship between PA and chronic kidney disease has increased. However, some of them have assessed PA using a non-validated questionnaire in this population [20] [21] [22] [23] . To date, no study has sought to determine the validity of using the IPAQ short version in the dialysis population, despite its use in previous studies [24] [25] [26] . From a statistical point of view, the bias observed for PA provided by non-validated questionnaires is likely to affect the relationship observed between PA and its determinants. Therefore, important determinants of PA may have gone undetected in previous studies, and conversely, established determinates of PA require confirmation using validated techniques. Given the relationship between quality of life, mortality and levels of PA, it is important not only to provide appropriate surveillance but also to facilitate comparisons with other populations. Moreover, the identification of PA correlates in the dialysis population is of importance for the development of more effective PA and public health programs with this population, given the potential health benefits that PA can promote in this patient group [27] [28] [29] .
In conclusion, this study found modest correlations between PA assessed by IPAQ (short form) and accelerometer among patients undergoing hemodialysis, suggesting appropriate validity. However, when analyzed by gender, positive relationships were only found for females, suggesting the IPAQ is only valid in this group. In addition, the IPAQ underestimated the time spent performing light PA, which is a concern given that these patients are likely to spend the majority of their time performing this type of PA. Although our findings warrant further exploration by others they suggest caution in the use of IPAQ among hemodialysis patients, especially among men and those who undertake high levels of light PA.
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